Podcast 31 Jan 2025
Can tumor activated therapy kill solid tumors?
Solid tumors are a big challenge. However, a new approach might provide the answer – tumor-activated Therapy. We discuss this with Seekyo Therapeutics’ CEO, Oury Chetboun
Cancer
- Latest Posts
In Depth 29 Jan 2025
Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic
Discover the treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to treat.
News and Trends 28 Jan 2025
ITM-11 succeeds in phase 3: The first big win for radiopharma?
Discover ITM and its cancer candidate ITM-11, as it brings one of the first big wins the radiopharmaceutical sector awaits.
In Depth 23 Jan 2025
mRNA, RNAi, circRNA, ASOs: A comparative guide to RNA therapeutics
In this review of RNA therapies, we paint an overview of what’s going on in a field that could address a number of diseases.
In Depth 17 Jan 2025
Are PD-1 and PD-L1 checkpoint inhibitors as good as we thought?
Checkpoint inhibitors, especially those targeting PD-1 and PD-L1, are exploding in popularity. But how much of it is hype?
Best in Biotech 16 Jan 2025
Ten first-in-class drugs on track for FDA approval in 2025
As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval in 2025.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 8 Jan 2025
Ten drugs to watch in 2025: will these therapies become blockbusters?
Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate’s latest report.
Best in Biotech 30 Dec 2024
Six biotech companies leading the way in India
Discover six of the top biotech companies in India, which is currently brimming with biotechs and a young, skilled workforce.
In Depth 25 Dec 2024
When biotech makes Christmas miracles a reality
Explore how biotech breakthroughs in 2024 have changed lives, bringing real Christmas miracles to patients and offering hope for the future.
In Depth 17 Dec 2024
Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic
A number of ovarian cancer vaccines are being evaluated including the world’s first cancer prevention vaccine, which recently received funding.
Best in Biotech 16 Dec 2024
10 biotech companies to watch in 2025
As 2025 is expected to be an exciting year for the biopharma industry, discover ten biotech companies to keep an eye on in 2025.
News and Trends 12 Dec 2024
Top biotech deals of November 2024
November has seen a variety of biotech deals take place to advance therapies across different stages in development.
ADVERTISEMENT
